Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 26, 2013, Pages 10753-10758

  Kolhar, Poornima ^a   Anselmo, Aaron C ^b   Gupta, Vivek ^b   Pant, Kapil ^c   Prabhakarpandian, Balabhaskar ^c   Ruoslahti, Erkki ^a,d   Mitragotri, Samir ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California   (United States)

^c CFD RESEARCH CORPORATION   (United States)

^d BURNHAM INSTITUTE   (United States)

Author keywords

Biodistribution; Cylinder; Drug delivery; Morphology; SMN

Indexed keywords

ANTIBODY; ANTIBODY COATED NANOPARTICLE; INTERCELLULAR ADHESION MOLECULE 1; NANOCOATING; NANOPARTICLE; UNCLASSIFIED DRUG;

ADHESION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN ENDOTHELIUM; BRAIN LEVEL; CELL CULTURE; CELL TRANSPORT; ENDOTHELIUM; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; LUNG ENDOTHELIUM; MICROCIRCULATION; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE LEVEL;

BIODISTRIBUTION; CYLINDER; DRUG DELIVERY; MORPHOLOGY; SMN;

ADHESIVENESS; ANIMALS; ANTIBODIES, MONOCLONAL; BRAIN; CELL LINE; DRUG DELIVERY SYSTEMS; ENDOTHELIUM, VASCULAR; FEMALE; LUNG; MICE; MICE, INBRED BALB C; MICROFLUIDICS; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; NANOSPHERES; NANOTECHNOLOGY; NANOTUBES; PARTICLE SIZE; RATS;

MUS;

EID: 84879536016     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1308345110     Document Type: Article

References (64)

1. Brekken RA, Thorpe PE (2001) Vascular endothelial growth factor and vascular targeting of solid tumors. Anticancer Res 21(6B):4221-4229.
2. Muzykantov VR (2001) Targeting of superoxide dismutase and catalase to vascular endothelium. J Control Release 71(1):1-21.
3. Tousoulis D, et al. (2006) Novel therapies targeting vascular endothelium. Endothelium 13(6):411-421.
4. Ruoslahti E (2002) Specialization of tumour vasculature. Nat Rev Cancer 2(2):83-90.
5. Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86(3):353-364.
6. Gallatin WM, Weissman IL, Butcher EC (1983) A cell-surface molecule involved in organ- specific homing of lymphocytes. Nature 304(5921):30-34.
7. Shimizu Y, Newman W, Tanaka Y, Shaw S (1992) Lymphocyte interactions with endothelial cells. Immunol Today 13(3):106-112.
8. Benson V, McMahon AC, Lowe HC (2007) ICAM-1 in acute myocardial infarction: A potential therapeutic target. Curr Mol Med 7(2):219-227.
9. Chang SS, et al. (1999) Prostate-specific membrane antigen is produced in tumorassociated neovasculature. Clin Cancer Res 5(10):2674-2681.
10. Ruggeri ZM (2007) Von Willebrand factor: Looking back and looking forward. Thromb Haemost 98(1):55-62.
11. Teesalu T, Sugahara KN, Ruoslahti E (2012) Mapping of vascular ZIP codes by phage display. Methods Enzymol 503:35-56.
12. Zhang L, Giraudo E, Hoffman JA, Hanahan D, Ruoslahti E (2006) Lymphatic zip codes in premalignant lesions and tumors. Cancer Res 66(11):5696-5706.
13. Ruoslahti E (2004) Vascular zip codes in angiogenesis and metastasis. Biochem Soc Trans 32(Pt3):397-402.
14. Liong M, et al. (2008) Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2(5):889-896.
15. Alexis F, Pridgen E, Molnar LK, Farokhzad OC (2008) Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm 5(4):505-515.
16. Zolnik BS, González-Fernández A, Sadrieh N, Dobrovolskaia MA (2010) Nanoparticles and the immune system. Endocrinology 151(2):458-465.
17. Moghimi SM, Hunter AC, Murray JC (2001) Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 53(2):283-318.
18. Decuzzi P, et al. (2010) Size and shape effects in the biodistribution of intravascularly injected particles. J Control Release 141(3):320-327.
19. Geng Y, et al. (2007) Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol 2(4):249-255.
20. Merkel TJ, et al. (2011) Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles. Proc Natl Acad Sci USA 108(2):586-591.
21. Mitragotri S, Lahann J (2009) Physical approaches to biomaterial design. Nat Mater 8(1):15-23.
22. Muro S, et al. (2008) Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. Mol Ther 16(8):1450-1458.
23. Wootton DM, Ku DN (1999) Fluid mechanics of vascular systems, diseases, and thrombosis. Annu Rev Biomed Eng 1(1):299-329.
24. Schoephoerster RT, Oynes F, Nunez G, Kapadvanjwala M, Dewanjee MK (1993) Effects of local geometry and fluid dynamics on regional platelet deposition on artificial surfaces. Arterioscler Thromb 13(12):1806-1813.
25. Lee SY, Ferrari M, Decuzzi P (2009) Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows. Nanotechnology 20(49):495101.
26. Doshi N, et al. (2010) Flow and adhesion of drug carriers in blood vessels depend on their shape: A study using model synthetic microvascular networks. J Control Release 146(2):196-200.
27. Champion JA, Mitragotri S (2006) Role of target geometry in phagocytosis. Proc Natl Acad Sci USA 103(13):4930-4934.
28. Malek AM, Alper SL, Izumo S (1999) Hemodynamic shear stress and its role in atherosclerosis. JAMA 282(21):2035-2042.
29. Rosano JM, et al. (2009) A physiologically realistic in vitro model of microvascular networks. Biomed Microdevices 11(5):1051-1057.
30. Wertheimer SJ, Myers CL, Wallace RW, Parks TP (1992) Intercellular adhesion molecule-1 gene expression in human endothelial cells. Differential regulation by tumor necrosis factor-alpha and phorbol myristate acetate. J Biol Chem 267(17):12030-12035.
31. Hayes SH, Seigel GM (2009) Immunoreactivity of ICAM-1 in human tumors, metastases and normal tissues. Int J Clin Exp Pathol 2(6):553-560.
32. Yan W, et al. (2002) [Expression of intercellular adhesion molecule-1 in different organs of the mice with endotoxic shock induced by lipopolysaccharide]. Sheng Li Xue Bao 54(1):71-74, Chinese.
33. Muro S, et al. (2006) Endothelial targeting of high-affinity multivalent polymer nanocarriers directed to intercellular adhesion molecule 1. J Pharmacol Exp Ther 317(3):1161-1169.
34. Jones AR, Shusta EV (2007) Blood-brain barrier transport of therapeutics via receptormediation. Pharm Res 24(9):1759-1771.
35. Huwyler J, Wu D, Pardridge WM (1996) Brain drug delivery of small molecules using immunoliposomes. Proc Natl Acad Sci USA 93(24):14164-14169.
36. Doshi N, Mitragotri S (2010) Macrophages recognize size and shape of their targets. PLoS One 5(4):e10051.
37. Yoo JW, Mitragotri S (2010) Polymer particles that switch shape in response to a stimulus. Proc Natl Acad Sci USA 107(25):11205-11210.
38. Gratton SE, et al. (2008) The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci USA 105(33):11613-11618.
39. Decuzzi P, Ferrari M (2008) The receptor-mediated endocytosis of nonspherical particles. Biophys J 94(10):3790-3797.
40. Glangchai LC, Caldorera-Moore M, Shi L, Roy K (2008) Nanoimprint lithography based fabrication of shape-specific, enzymatically-triggered smart nanoparticles. J Control Release 125(3):263-272.
41. Gratton SE, et al. (2007) Nanofabricated particles for engineered drug therapies: A preliminary biodistribution study of PRINT nanoparticles. J Control Release 121(1-2): 10-18.
42. Champion JA, Mitragotri S (2009) Shape induced inhibition of phagocytosis of polymer particles. Pharm Res 26(1):244-249.
43. Shuvaev VV, et al. (2011) Endothelial targeting of antibody-decorated polymeric filomicelles. ACS Nano 5(9):6991-6999.
44. Godin B, et al. (2012) Discoidal porous silicon particles: Fabrication and biodistribution in breast cancer bearing mice. Adv Funct Mater 22(20):4225-4235.
45. Chu KS, et al. (2012) Plasma, tumor and tissue pharmacokinetics of Docetaxel delivered via nanoparticles of different sizes and shapes in mice bearing SKOV-3 human ovarian carcinoma xenograft. Nanomedicine 10.1016/j.nano.2012.11.008.
46. Park JH, et al. (2008) Magnetic iron oxide nanoworms for tumor targeting and imaging. Adv Mater 20(9):1630-1635.
47. Chauhan VP, et al. (2011) Fluorescent nanorods and nanospheres for real-time in vivo probing of nanoparticle shape-dependent tumor penetration. Angew Chem Int Ed Engl 50(48):11417-11420.
48. Arnida MM, Janát-Amsbury MM, Ray A, Peterson CM, Ghandehari H (2011) Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. Eur J Pharm Biopharm 77(3):417-423.
49. Barua S, et al. (2013) Particle shape enhances specificity of antibody-displaying nanoparticles. Proc Natl Acad Sci USA 110(9):3270-3275.
50. Misra A, Ganesh S, Shahiwala A, Shah SP (2003) Drug delivery to the central nervous system: A review. J Pharm Pharm Sci 6(2):252-273.
51. Calderon AJ, et al. (2011) Optimizing endothelial targeting by modulating the antibody density and particle concentration of anti-ICAM coated carriers. J Control Release 150(1):37-44.
52. Decuzzi P, Lee S, Decuzzi M, FerrariM (2004) Adhesion of microfabricated particles on vascular endothelium: A parametric analysis. Ann Biomed Eng 32(6):793-802.
53. Han J, et al. (2012) Acute and chronic shear stress differently regulate endothelial internalization of nanocarriers targeted to platelet-endothelial cell adhesion molecule-1. ACS Nano 6(10):8824-8836.
54. Prabhakarpandian B, et al. (2008) Synthetic microvascular networks for quantitative analysis of particle adhesion. Biomed Microdevices 10(4):585-595.
55. Decuzzi P, Ferrari M (2006) The adhesive strength of non-spherical particles mediated by specific interactions. Biomaterials 27(30):5307-5314.
56. Liu J, et al. (2010) Computational model for nanocarrier binding to endothelium validated using in vivo, in vitro, and atomic force microscopy experiments. Proc Natl Acad Sci USA 107(38):16530-16535.
57. Muzykantov VR, Radhakrishnan R, Eckmann DM (2012) Dynamic factors controlling targeting nanocarriers to vascular endothelium. Curr Drug Metab 13(1):70-81.
58. Bianco A, Kostarelos K, Prato M (2005) Applications of carbon nanotubes in drug delivery. Curr Opin Chem Biol 9(6):674-679.
59. Jiang X, et al. (2013) Plasmid-templated shape control of condensed DNA-block copolymer nanoparticles. Adv Mater 25(2):227-232.
60. Huang X, El-Sayed IH, Qian W, El-Sayed MA (2006) Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc 128(6):2115-2120.
61. Shuvaev VV, et al. (2009) Targeted detoxification of selected reactive oxygen species in the vascular endothelium. J Pharmacol Exp Ther 331(2):404-411.
62. Ruoslahti E, Pierschbacher MD (1987) New perspectives in cell adhesion: RGD and integrins. Science 238(4826):491-497.
63. Ruoslahti E (2012) Peptides as targeting elements and tissue penetration devices for nanoparticles. Adv Mater 24(28):3747-3756.
64. Doshi N, et al. (2012) Platelet mimetic particles for targeting thrombi in flowing blood. Adv Mater 24(28):3864-3869.